Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis superimposed on biopsy-proven

Toshiharu Ninomiya1, Hidetoshi Kanai, Makoto Hirakawa

  • 1Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Insights

This case highlights myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis co-occurring with diabetic nephrosclerosis. Early renal biopsy is crucial for diabetic patients with declining kidney function to diagnose concurrent glomerular diseases.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Diabetic nephrosclerosis is a common cause of chronic kidney disease.
  • Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis is a rare but serious autoimmune kidney disease.

Observation:

  • A 78-year-old male with pre-existing diabetic nephrosclerosis presented with acute renal failure and respiratory symptoms.
  • Elevated MPO-ANCA titers and a second renal biopsy confirmed superimposed necrotizing glomerulonephritis with crescents.

Findings:

  • Treatment with corticosteroids resolved respiratory symptoms and MPO-ANCA titers.
  • Despite treatment, renal function did not recover, necessitating hemodialysis.

Implications:

  • This case underscores the importance of renal biopsy in diabetic patients with rapidly declining renal function to identify coexisting glomerular diseases.
  • Prompt diagnosis and management of MPO-ANCA-associated glomerulonephritis can prevent severe systemic complications.